Global Dravet Syndrome Treatment Market 2023-2027

PUBLISHED: December 21, 2022

PAGES: 163 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

Technavio has been monitoring the Dravet syndrome treatment market and is forecast to grow by $575.14 mn during 2022-2027, accelerating at a CAGR of 9.6% during the forecast period. Our report on the Dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for DS treatment.

Technavio's Dravet syndrome treatment market is segmented as below:

By Product

SGDs
TGDs
FDGs

By Distribution Channel

Hospital pharmacy
Retail pharmacy
E- Commerce
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increased use of new-generation drugs as one of the prime reasons driving the Dravet syndrome treatment market growth during the next few years. Also, advances in biomedical sciences and a strong pipeline will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the Dravet syndrome treatment market covers the following areas:

Dravet syndrome treatment market sizing
Dravet syndrome treatment market forecast
Dravet syndrome treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Dravet syndrome treatment market vendors that include AbbVie Inc., BIOCODEX SAS, Cadila Healthcare Ltd., Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., UCB SA, Viatris Inc., and Xenon Pharmaceuticals Inc. Also, the Dravet syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR45344

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global dravet syndrome treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global dravet syndrome treatment market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 SGDs - Market size and forecast 2022-2027
Exhibit 34: Chart on SGDs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on SGDs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on SGDs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on SGDs - Year-over-year growth 2022-2027 (%)
6.4 TGDs - Market size and forecast 2022-2027
Exhibit 38: Chart on TGDs - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on TGDs - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on TGDs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on TGDs - Year-over-year growth 2022-2027 (%)
6.5 FDGs - Market size and forecast 2022-2027
Exhibit 42: Chart on FDGs - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on FDGs - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on FDGs - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on FDGs - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Product
Exhibit 46: Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 47: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 48: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 49: Chart on Comparison by Distribution Channel
Exhibit 50: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 51: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 55: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 E- Commerce - Market size and forecast 2022-2027
Exhibit 59: Chart on E- Commerce - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on E- Commerce - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on E- Commerce - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on E- Commerce - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Distribution Channel
Exhibit 67: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key news
Exhibit 119: AbbVie Inc. - Key offerings
12.4 BIOCODEX SAS
Exhibit 120: BIOCODEX SAS - Overview
Exhibit 121: BIOCODEX SAS - Product / Service
Exhibit 122: BIOCODEX SAS - Key offerings
12.5 Encoded Therapeutics Inc.
Exhibit 123: Encoded Therapeutics Inc. - Overview
Exhibit 124: Encoded Therapeutics Inc. - Product / Service
Exhibit 125: Encoded Therapeutics Inc. - Key offerings
12.6 Epygenix Therapeutics Inc.
Exhibit 126: Epygenix Therapeutics Inc. - Overview
Exhibit 127: Epygenix Therapeutics Inc. - Product / Service
Exhibit 128: Epygenix Therapeutics Inc. - Key offerings
12.7 H Lundbeck AS
Exhibit 129: H Lundbeck AS - Overview
Exhibit 130: H Lundbeck AS - Product / Service
Exhibit 131: H Lundbeck AS - Key offerings
12.8 Jazz Pharmaceuticals Plc
Exhibit 132: Jazz Pharmaceuticals Plc - Overview
Exhibit 133: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 134: Jazz Pharmaceuticals Plc - Key news
Exhibit 135: Jazz Pharmaceuticals Plc - Key offerings
12.9 Johnson and Johnson
Exhibit 136: Johnson and Johnson - Overview
Exhibit 137: Johnson and Johnson - Business segments
Exhibit 138: Johnson and Johnson - Key news
Exhibit 139: Johnson and Johnson - Key offerings
Exhibit 140: Johnson and Johnson - Segment focus
12.10 Lupin Ltd.
Exhibit 141: Lupin Ltd. - Overview
Exhibit 142: Lupin Ltd. - Product / Service
Exhibit 143: Lupin Ltd. - Key news
Exhibit 144: Lupin Ltd. - Key offerings
12.11 PTC Therapeutics Inc.
Exhibit 145: PTC Therapeutics Inc. - Overview
Exhibit 146: PTC Therapeutics Inc. - Business segments
Exhibit 147: PTC Therapeutics Inc. - Key offerings
Exhibit 148: PTC Therapeutics Inc. - Segment focus
12.12 Stoke Therapeutics Inc.
Exhibit 149: Stoke Therapeutics Inc. - Overview
Exhibit 150: Stoke Therapeutics Inc. - Product / Service
Exhibit 151: Stoke Therapeutics Inc. - Key offerings
12.13 Sun Pharmaceutical Industries Ltd.
Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Supernus Pharmaceuticals Inc.
Exhibit 155: Supernus Pharmaceuticals Inc. - Overview
Exhibit 156: Supernus Pharmaceuticals Inc. - Product / Service
Exhibit 157: Supernus Pharmaceuticals Inc. - Key offerings
12.15 Takeda Pharmaceutical Co. Ltd.
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.16 UCB SA
Exhibit 162: UCB SA - Overview
Exhibit 163: UCB SA - Product / Service
Exhibit 164: UCB SA - Key offerings
12.17 Viatris Inc.
Exhibit 165: Viatris Inc. - Overview
Exhibit 166: Viatris Inc. - Business segments
Exhibit 167: Viatris Inc. - Key offerings
Exhibit 168: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations

Product Code: IRTNTR45344

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global dravet syndrome treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on SGDs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on SGDs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on SGDs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on SGDs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on TGDs - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on TGDs - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on TGDs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on TGDs - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on FDGs - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on FDGs - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on FDGs - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on FDGs - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits48: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Distribution Channel
Exhibits50: Data Table on Comparison by Distribution Channel
Exhibits51: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on E- Commerce - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on E- Commerce - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on E- Commerce - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on E- Commerce - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key news
Exhibits119: AbbVie Inc. - Key offerings
Exhibits120: BIOCODEX SAS - Overview
Exhibits121: BIOCODEX SAS - Product / Service
Exhibits122: BIOCODEX SAS - Key offerings
Exhibits123: Encoded Therapeutics Inc. - Overview
Exhibits124: Encoded Therapeutics Inc. - Product / Service
Exhibits125: Encoded Therapeutics Inc. - Key offerings
Exhibits126: Epygenix Therapeutics Inc. - Overview
Exhibits127: Epygenix Therapeutics Inc. - Product / Service
Exhibits128: Epygenix Therapeutics Inc. - Key offerings
Exhibits129: H Lundbeck AS - Overview
Exhibits130: H Lundbeck AS - Product / Service
Exhibits131: H Lundbeck AS - Key offerings
Exhibits132: Jazz Pharmaceuticals Plc - Overview
Exhibits133: Jazz Pharmaceuticals Plc - Product / Service
Exhibits134: Jazz Pharmaceuticals Plc - Key news
Exhibits135: Jazz Pharmaceuticals Plc - Key offerings
Exhibits136: Johnson and Johnson - Overview
Exhibits137: Johnson and Johnson - Business segments
Exhibits138: Johnson and Johnson - Key news
Exhibits139: Johnson and Johnson - Key offerings
Exhibits140: Johnson and Johnson - Segment focus
Exhibits141: Lupin Ltd. - Overview
Exhibits142: Lupin Ltd. - Product / Service
Exhibits143: Lupin Ltd. - Key news
Exhibits144: Lupin Ltd. - Key offerings
Exhibits145: PTC Therapeutics Inc. - Overview
Exhibits146: PTC Therapeutics Inc. - Business segments
Exhibits147: PTC Therapeutics Inc. - Key offerings
Exhibits148: PTC Therapeutics Inc. - Segment focus
Exhibits149: Stoke Therapeutics Inc. - Overview
Exhibits150: Stoke Therapeutics Inc. - Product / Service
Exhibits151: Stoke Therapeutics Inc. - Key offerings
Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits155: Supernus Pharmaceuticals Inc. - Overview
Exhibits156: Supernus Pharmaceuticals Inc. - Product / Service
Exhibits157: Supernus Pharmaceuticals Inc. - Key offerings
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits159: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits161: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits162: UCB SA - Overview
Exhibits163: UCB SA - Product / Service
Exhibits164: UCB SA - Key offerings
Exhibits165: Viatris Inc. - Overview
Exhibits166: Viatris Inc. - Business segments
Exhibits167: Viatris Inc. - Key offerings
Exhibits168: Viatris Inc. - Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations